N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients. - Wikidata - awgldk - TriplyDB

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

http://www.wikidata.org/entity/Q34280520

about

Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer Glyco-epitope Diversity: An Evolving Area of Glycomics Research and Biomarker Discovery.Competition between serum IgG, IgM, and IgA anti-glycan antibodies Targeting N-glycan cryptic sugar moieties for broad-spectrum virus neutralization: progress in identifying conserved molecular targets in viruses of distinct phylogenetic origins.MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.

P2860

Q33605256-F70EB884-0149-422E-B538-D3B14381A825 Q34069601-DEB04020-3287-461C-88CA-AB121BCAEC37 Q34449556-2D3D897E-484F-4BC3-9D6D-307046C9600C Q35217313-5163D0AA-CB3B-4899-AE58-0D4DAFBB98FB Q36248197-72D303D6-6927-4686-9790-A711C5EEA3BB Q36256730-0FEB27CB-CD22-4C57-82DD-B1BF9AC4CEB6

P2860

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

http://www.wikidata.org/entity/Q34280520

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@ast

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@en

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@nl

type

label

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@ast

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@en

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@nl

prefLabel

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@ast

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@en

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@nl

P1433

Q34280520-672B35A6-28A5-4604-8E04-878AC3B636DB

P1476

Q34280520-1574CDE3-B173-4EC6-B71A-44E7568F2962

P2093

Q34280520-74F3FEF6-3427-4181-820C-81928236D801

P2860

Q34280520-068F6382-66FC-4980-960C-D93A716CCCEF

Q34280520-0818752A-E4E5-40E3-8EAE-0EE53C472C9F

Q34280520-116F7C4E-C9EC-407E-B3D7-2C9D58E174C6

Q34280520-1624DFB9-AC49-4AF7-A4C0-150BCE12699B

Q34280520-2CBD2639-FAEF-40B7-A0C8-3B58AE482A26

Q34280520-347D9DEE-C831-4408-A969-D1B086CD90FB

Q34280520-3561C55D-F940-4DF9-912F-355F7E5D5580

Q34280520-4873BB6A-88A8-4917-A33C-D2C623999F59

Q34280520-523A0A0E-A15F-47C8-99BA-D629D791460A

Q34280520-5B5BF8F1-312F-4314-9971-C13B79F1E478

P304

Q34280520-E7BC6D41-4A31-4FB5-BD25-7026FA8B4EE5

P31

Q34280520-00F81159-EBA8-44E7-8147-B1B38C2C8085

P356

Q34280520-640128A1-33E1-44C2-9463-2973BCAA1E64

P433

Q34280520-A0B3F314-800E-41EF-B7E7-0AC1B60EE3F9

P478

Q34280520-F0E71353-CB28-4885-A2FF-F8358E8D7ECC

P577

Q34280520-28DD8713-AA67-4B1C-820A-978B3C6E40C7

P698

Q34280520-15356743-9E0D-48EE-914C-0011BF7631B4

P921

Q34280520-CCD16F3F-B0AA-40BA-A5DF-CD8EF8FA058D

P932

Q34280520-6EE902EE-0CAC-488B-87F0-BC94057BF11F

P356

P1433

Journal of Proteomics and Bioinformatics

P1476

N-glycan Cryptic Antigens as Active Immunological Targets in Prostate Cancer Patients.

@en

P2093

Denong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

Toward oligosaccharide- and glycopeptide-based HIV vaccines.

Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.

Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen.

Reaction of germinal centers in the T-cell-independent response to the bacterial polysaccharide alpha(1-->6)dextran.

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.

Enhanced immune recognition of cryptic glycan markers in human tumors.

P304

90-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4172/JPB.1000218

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25284963

http://www.w3.org/2001/XMLSchema#string

P921

P932

4183219

http://www.w3.org/2001/XMLSchema#string